ClinicalTrials.gg
CompletedNCT03900533Updated Oct 29, 2024

Emotion Regulation Group Skills Training for Adolescents and Parents

An interventional study of Adjunctive group emotion regulation skills training and Treatment as usual in Behavioral Symptoms and Emotional Instability, sponsored by Region Östergötland. Completed at 1 site in Sweden. Open to participants aged 14 Years to 17 Years. Per ClinicalTrials.gov, last updated 2024-10-29.

Sponsored by Region Östergötland · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
119
Allocation
Randomized
Ages
14 Years to 17 Years
Sex
All
01

Study summary

To evaluate if emotion regulation group therapy skills training for adolescents and parents is an efficacious treatment when delivered as adjunctive to treatment as usual compared to a control group consisting of treatment as usual.

02

Conditions studied

  • Behavioral Symptoms
  • Emotional Instability

Browse trials for

Keywords

  • child psychiatry
  • emotion regulation skills training
03

In context

Behavioral Symptoms

135 studies on the registry are indexed under Behavioral Symptoms; 18 are open to participants now.

This study's enrollment of 119 is above the median of 93 across 114 interventional studies indexed under Behavioral Symptoms.

Browse Behavioral Symptoms studies →

Lead sponsor

Region Östergötland is the lead sponsor of 29 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being enrolled as a patient at the child- and adolescent psychiatric clinic in Linköping
  • Having an adult participant joining the skills training
  • Being between the ages of 14-17 years
  • Having sufficient knowledge of the Swedish language

Exclusion criteria

Exclusion criteria:

  • Clinical diagnosis of schizophrenia
  • Clinical diagnosis of psychosis
  • Clinical diagnosis of severe anorexia nervosa
  • Clinical diagnosis of severe autism spectrum disorder
  • Having a cognitive disability
  • Having an ongoing drug or alcohol abuse
  • Clinical diagnosis of bipolar disorder
  • Insufficient knowledge of the Swedish language
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
119 participants (actual)

Study arms

  • Experimental
    Adjunctive group emotion regulation skills training

    Participants will receive a 7 week group emotion regulation skills training together with parents adjacent to treatment as usual provided by the child- and adolescent psychiatric clinic

    Behavioral: Adjunctive group emotion regulation skills training

  • Active comparator
    Treatment as usual (TAU)

    Participants will receive treatment as usual for 7 weeks as provided by the child- and adolescent psychiatric clinic

    Behavioral: Treatment as usual

Interventions

  • BehavioralAdjunctive group emotion regulation skills training

    The adjunctive emotion regulation skills training is delivered in a group format once a week during 7 weeks to adolescents and parents jointly together with treatment as usual

  • BehavioralTreatment as usual

    Treatment as usual at the child- and adolescent psychiatric clinic is delivered during 7 weeks

06

What researchers measure

Primary outcomes

  1. Difficulties with Emotion Regulation Scale (DERS)

    Difficulties with Emotion Regulation Scale measures difficulties with emotion regulation. It contains a total of 36 items that are rated on a Likert scale between 1-5. Total score ranges between 36-180 with higher scores indicating more difficulties with emotion regulation. The scale has 6 subscales: nonacceptance (ranging from 6-30); goals (ranging from 5-25); impulse (ranging from 6-30); awareness (ranging from 6-30); strategies (ranging from 8-40) and clarity (ranging from 5-25).

    Time frame: Change from baseline at 7 weeks and at 3 months

Secondary outcomes

  1. Beck's Anxiety Inventory (BAI)

    Beck's Anxiety Inventory measures symptoms of anxiety with 21 items rated on a four-graded scale (0-3). Total scores range from 0-63. Higher scores indicate higher levels of anxiety.

    Time frame: Change from baseline at 7 weeks and at 3 months

  2. Montgomery Åsberg Depression Rating Scale, self-report version (MADRS-S).

    Montgomery Åsberg Depression Rating Scale measures symptoms of depression. Its main purpose is to monitor the development of symptoms during treatment. The scale consists of 9 items, which are graded from zero to six. Total scores range from 0-54. Higher scores indicate higher level of depression symptoms.

    Time frame: Change from baseline at 7 weeks and at 3 months

  3. Global Assessment Scale for Children (C-GAS)

    The Global Assessment Scale for Children measures global functioning on a scale that ranges from 0 to 100 with higher scores indicating higher global functioning.

    Time frame: Change from baseline at 7 weeks and at 3 months

  4. Brunnsviken Brief Quality of Life (BBQ)

    Brunnsviken Brief Quality of Life measures quality of Life in a total of 12 items (6 different areas of life). Satisfaction and how important the different areas of life are, are rated from 0-4. Total scores range from 0-96 with high scores indicating higher levels of quality of life.

    Time frame: Change from baseline at 7 weeks and at 3 months

  5. Toronto Alexithymia Scale (TAS-20)

    Toronto Alexithymia Scale measures alexithymia. It contains a total of 20 items with 3 subscales (difficulties describing feelings: 7 items ranging from 7-35, difficulties identifying feelings: 5 items ranging from 5-25 and externally oriented thinking: 8 items ranging from 8-40). Total scores range from 20-100 with higher scores indicating higher levels of alexithymia.

    Time frame: Change from baseline at 7 weeks and at 3 months

  6. Levels of Emotional Awareness (LEAS-C)

    Measures awareness of emotions, i.e., the ability to identify and describe own and others' emotions. The children's version used in the present study consists of 12 situations, in which the child is asked to describe which emotions he/she and another person would experience in a given situation. Answers are rated by an external rater on a five-grade scale divided into the three subscales: self, other and total.

    Time frame: Change from baseline at 7 weeks and at 3 months

07

Study locations

1 site
  • Region Östergötland BUP-kliniken
    Linköping, 581 85, Sweden
08

References and documents

Publications

  • Holmqvist Larsson K, Falkenstrom F, Andersson G, Stern H, Bolmgren L, Engstrom T, Kallstrom V, Nilsson M, Pettersson E, Seesing F, Ohman T, Osterman K, Zetterqvist M. Emotion regulation skills training for adolescents and parents in a clinical setting: a randomised controlled trial. Child Adolesc Psychiatry Ment Health. 2026 May 28;20(1):85. doi: 10.1186/s13034-026-01098-1. PubMed 42210292 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03900533
Lead sponsor
Region Östergötland
Responsible party
Maria Zetterqvist (Principal Investigator, Region Östergötland) — Principal investigator
First posted
Apr 3, 2019
Start date
Apr 2, 2019
Primary completion
Sep 4, 2023
Completion
Sep 4, 2023
Last update
Oct 29, 2024

Study contacts

Maria A Zetterqvist, PhD
principal investigator · Region Ostergotland/Linköping universitet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion